Society for Neuro-Oncology Announces Susan Chang, M.D. as New Editor-In-Chief for Neuro-Oncology
The Society for Neuro-Oncology is pleased to announce the appointment of Susan Chang, M.D., as the new Editor-in-Chief of its flagship journal, Neuro-Oncology
. Dr. Chang succeeds Dr. Kenneth Aldape.
Dr. Chang is a Professor of Neurological Surgery at the University of California, San Francisco Weill Institute for Neurosciences, and co-leader of the Neuro-Oncology Program at the Helen Diller Family Comprehensive Cancer Center. No stranger to editorial leadership, she formerly served as the Founding Editor-in-Chief of Neuro-Oncology’s
sister title, Neuro-Oncology Practice
. Her outstanding record of academic excellence, past service to the Society, and familiarity with the neuro-oncology publishing enterprise makes her the ideal candidate to advance the educational mission of the journal.
Commenting on her appointment, Dr. Chang said: “I am humbled and honored to be named to this role. I stand on the shoulders of giants – former Editors Drs. Darell Bigner, W.K. Alfred Yung, Patrick Wen, and Kenneth Aldape – and I am eager to build on their outstanding efforts to take the journal to new heights. I look forward to working with the leaders of ASNO, EANO and SNO, the Editorial Board, and all neuro-oncology stakeholders, as we build community, increase diversity, and generate data-driven education and innovation for our readers around the world.”
The Society for Neuro-Oncology wishes to express its deep gratitude to the journal’s former Editor-in-Chief, Ken Aldape, M.D. Under Dr. Aldape’s leadership, the journal has flourished, with the publication today boasting an all-time high Clarivate Impact Factor of 12.30, which ranks the journal 7th among all 208 Clinical Neurology titles, and 19th among all 244 Oncology titles. Given the relatively narrow editorial focus of Neuro-Oncology
as a subspecialty publication, these are remarkable statistics, and the Society is both grateful and proud of the progress the journal has made under Dr. Aldape’s editorial direction.
is an international, peer-reviewed journal, dedicated to providing superior and rapid publication of original research articles, editorials, reviews, and letters on all aspects of the field of neuro-oncology. The journal was established in 1999 and is published monthly by Oxford University Press.